Evidence map›Paper›PMID 25511759›Full record

ArticleNature reviews. Nephrology2015

Renal transplantation in 2014: renal transplantation-reducing risk and improving outcome.

Dennis A Hesselink, Willem Weimar

Abstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dennis A HesselinkErasmus MC, University Medical Centre Rotterdam, Department of Internal Medicine, Division of Nephrology and Renal Transplantation, Room D-427, P.O. Box 2040, Rotterdam, 3000 CA, Netherlands.
Willem WeimarErasmus MC, University Medical Centre Rotterdam, Department of Internal Medicine, Division of Nephrology and Renal Transplantation, Room D-427, P.O. Box 2040, Rotterdam, 3000 CA, Netherlands.
Erasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies published in 2014 might facilitate improvements in the treatment and long-term care of renal transplant recipients. The potential risks of living kidney donation, the efficacy and safety of alemtuzumab-based induction therapy, and the treatment of chronic hepatitis E virus infection have been addressed.

Indexed as

Kidney TransplantationHumansLiving DonorsPostoperative ComplicationsRisk FactorsTreatment Outcome

Identifiers

PMID25511759
OpenAlexW1973327215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.